Navigation Links
The Reduction of Eye Fatigue Improves Vision in Older Subjects
Date:8/5/2009

BURLINGTON, N.J., Aug. 5 /PRNewswire/ -- Most people over the age of 40 begin to experience Presbyopia which is the increased difficulty to focus on nearby objects. Although this age related phenomena is usually assisted by reading glasses, a current study performed at the Kajita Clinic in Tokyo, Japan and published in March, 2009 has shown significant improvement in the ability to focus on nearby objects in older subjects (mean age of 53.9 +/- 5.1 years) with supplementation of the antioxidant, astaxanthin.

The researchers suggest that the underlying reason for the improved accommodation ability in the test subjects may be due to the positively activated functions of three muscles in the eye; the constrictor pupillae muscle and dilator pupillae muscle working in coordination with the ciliary muscle. Astaxanthin has been shown in other studies to improve muscle endurance and recovery.

Although the basic measure for presbyopia is to wear glasses, the researchers also suggest that astaxanthin supplementation may slow down the progression of presbyopia and improve asthenopia (eye fatigue).

The current study is the tenth human clinical sponsored by Fuji Chemical Industry Co., Ltd. supporting the role of astaxanthin in the reduction of eye fatigue. The studies were performed over the past 7 years at more than 6 different universities and research institutes.

Fuji Chemical is a Japanese pharmaceutical company with a 60+ year history and the maker of AstaReal astaxanthin. Fuji is the world's leading producer of natural astaxanthin for human nutritional use with state of the art facilities in Hawaii, Sweden and Japan.

Some of the other areas of astaxanthin research that Fuji is actively supporting include cardiovascular, diabetes and metabolic syndrome. Fuji Chemical also holds seven patents for astaxanthin in human application as well as numerous pending patents. Fuji's AstaReal brand of astaxanthin is approved for use in nutritional supplementation in the U.S., Europe, and Japan, as well as other markets worldwide.

For more information: contact@fujihealthscience.com

    For additional information, please contact:
    Yasuko Kuroda
    Fuji Health Science, Inc.
    3 Terri Lane, Unit 12
    Burlington, NJ 08016
    contact@fujihealthscience.com
    tel: 609 386 3030  fax: 609 386 3033


'/>"/>
SOURCE Fuji Health Science, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New Surgical Device Revolutionizes Face Lifts, Abdominoplasty and Breast Reduction Surgery Promising Patients Quicker Recovery Time, Less Pain and Fewer Bruises
2. Lung volume reduction surgery shown to prolong and improve life for some emphysema patients
3. Fat Reduction Market in Europe to Soar Despite Economic Downturn
4. Federal Judge Orders Schwarzenegger Administration to Comply with Order That Blocks State Reduction for IHSS Worker Wages
5. Caraco Pharmaceutical Laboratories, Ltd. Announces an Indefinite Reduction in its Workforce
6. Hospital Bedside Technology Solution Results in 74 Percent Reduction in Heart Failure Readmission Rate
7. Employees Increasingly Accept and Understand Reductions in Health Plan Benefits and Premium-Cost Sharing
8. Studies Show Groundbreaking 22% Reduction in Depression Symptoms in 4 Hours
9. Maricopa Integrated Health System Reports 90 Percent Reduction in Pressure Ulcers
10. Pharmaceutical Companies Seek to Balance Quality Assurance & Cost Reduction
11. AstraZeneca Studies Show Relief of Nighttime Heartburn and Reduction in GERD-Related Sleep Disturbances
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... 06, 2016 , ... For many years, Andrew G. Zubinas has ... The beauty of the Lithuanian language and its poetry inspired him in ... Zubinas lyrically explores all aspects of a living, breathing forest where nothing ever stays ...
(Date:12/5/2016)... ... December 05, 2016 , ... “Epilepsy ... through tomorrow, December 6th, sparks a conversation about epilepsy, bearing down on the ... 26 people will be diagnosed with epilepsy within their lifetime. With such a ...
(Date:12/5/2016)... Reading, PA (PRWEB) , ... December 05, 2016 , ... ... partner in the United States and Canada for distribution of their natural fruits ... Hansen colors line is an exciting addition to our Life Sciences product portfolio,” ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Partners ("GPP") portfolio company, today announced it has acquired the assets of ... was previously a subsidiary of Chiltern International and focuses on clinical trial ...
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... The new ... the individual looking to buy neoprene knee sleeves for lifting and any ... design focuses heavily on two main aspects to provide a higher quality knee sleeve ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... Eisai Inc. announced today new analyses and ... of the American Epilepsy Society (AES). ... adjunctive therapy for the treatment of partial onset seizures ... generalized tonic-clonic seizures (PGTC) in patients with epilepsy who ... Important Safety Information for FYCOMPA, including Boxed WARNING for ...
(Date:12/5/2016)... , Dec 5, 2016 Research and ... and Pregnancy Rapid Test Market Size, Share, Development, Growth and Demand ... ... The global female fertility and pregnancy rapid test market is ... global Female fertility and pregnancy rapid test market is witnessing high ...
(Date:12/5/2016)... AVIV, Israel , December 5, 2016 ... to identifying, in-licensing and developing promising therapeutic candidates, presents positive ... for BL-8040, the Company,s leading oncology platform at the ongoing ... in San Diego, California . ... , , ...
Breaking Medicine Technology: